Screening of a novel-substituted furan compound for analgesic activity in mice


  • Nithya Karnam Department of Pharmacology, G. Melmaruvathur Adhiparasakthi Institute of Medical Sciences and Research, Tamil Nadu - 603319, India
  • Jayakumar J. K. Department of Pharmacology, Sri Devaraj Urs Medical College, Tamaka, Kolar, Karnataka - 563101, India
  • Supriya . Department of Pharmacology, Sri Sai Dental College and Research Institute, Shapuram, Srikakulam, Andhra Pradesh, India
  • Revanaswamy . Department of Pharmacology, PES Institute of Medical Sciences and Research, Kuppam, Andhra Pradesh -517425, India



Morphine, Aspirin, Novel-substituted furan compound, Analgesic activity


Background: Pain is an unpleasant sensation and is the most primitive of all senses. It is a major symptom in many medical conditions and can significantly interfere with a person's quality of life and general functioning. Analgesics like opioids and NSAIDS are used to treat pain but due to their side effects on long term use it is necessary to develop a compound with reduced side effects. Hence the present study was focused on screening of novel compound of novel compound 2-(4-nitrophenylimino)-N-cyclohexyl-4,5 diphenylfuran-3- carboxamide (AMSM-2(a-k) for analgesic activity in mice.

Methods: The analgesic activity of test compound AMSM-2(a-k) at different doses (5 mg/kg, 10 mg/kg and 20 mg/kg) was evaluated by using Eddy’s hot plate for determining central analgesic activity using morphine (5 mg/kg) as standard drug, acetic acid induced writhing test for peripheral analgesic activity and formalin induced writhing test to evaluate both central and peripheral analgesic activity using aspirin as standard drug (300 mg/kg). The percentages of inhibition of writhing’s were calculated for acetic acid and formalin induced pain model. The statistical analysis was done using one way ANOVA followed by Dunnett’s test. All values with P <0.05 were considered statistically significant.

Results: In hot plate method, the percentage increase in the latency of licking for test compound AMSM-2(a-k) at 20 mg/kg was significantly comparable to standard drug. Morphine (10 mg/kg) and AMSM-2(a-k) (20 mg/kg) gave the peak effect at 90 minutes. In acetic acid induced writhing method the percentage inhibition for AMSM-2(a-k) (20 mg/kg) was 73.93% for up to 20 min and for aspirin was 57.12%. In formalin induced paw licking method, the percentage inhibition in licking response in the early phase for AMSM-2(a-k) with 20 mg/kg was 63.23% which was more significant than the standard drug aspirin (100 mg/kg) which gave a percentage inhibition of 42.17%. In the late phase the percentage inhibition in licking response for AMSM-2(a-k) (20 mg/kg) was 74.33% and aspirin (100 mg/kg) gave a percentage inhibition of 60.82%.

Conclusions: The test drug AMSM-2(a-k) at a dose of 20 mg/kg showed promising results in hot plate method, equally comparable to the standard drug morphine and in acetic acid induced writhing test and formalin induced paw licking (early and late phase) methods they are more significant than the standard drug aspirin. This suggests AMSM-2(a-k) had potential central and peripheral analgesic activity.


Bonica JJ. Derived: International association for the study of pain: pain definitions. Pain is an unpleasant sensory and emotional experience associated with actual or potential tissue damage, or described in terms of such damage. The need of taxonomy. Pain. 1979;6(3):247-8.

Merskey H, Bogduk N. Classification of chronic pain. 2nd edition. Seattle: International Association for the Study of Pain press; 1994:3-4.

Woolf CJ, Bennett GJ, Doherty M, Dubner R, Kidd B, Koltzenburg M, et al. Towards a mechanism-based classification of pain? Pain. 1998;77(3):227-9.

Woolf CJ. What is this thing called pain? J of Clin Invest. 2010;120(11):3742-4.

Laurence DR, Benneth PN, Brown MJ. Clinical Pharmacology. 8th edn. Edinburgh: ChurchHill Livingstone; 1997.

Eddy NB, Leimbach D. Synthetic analgesics: II. Dithenylbutenyl and dithienyl-butylamines. J Pharmacol Exp Ther. 1953;107:385-93.

Hunskaar HS, Fasmer OB, Hole K. Formalin test in mice, a useful technique for evaluating mild analgesics. J Neurosci Methods. 1985;14:69-7.

Dubuisson D, Dennis SG. The formalin test: a quantitative study of the analgesic effects of morphine, meperidine and brain stem stimulation in rats and cats. Pain. 1977;4:161-74.

Vane JR, Bakhle YS, Botting RM. Cyclooxygenases 1 and 2. Ann Rev Pharmacol Toxicol. 1998;38:97-120.

Siegmund E, Cadnus R, Lu G. A method for evaluating both non-narcotic and narcotic analgesics. Proc Soc Exp Biol. 1957;95:729-31.

BerkenKopf JW, Weichmann BM. Production of prostacyclin in mice following intraperitoneal injection of acetic acid, phenylbenzoquinone and zymosan: Its role in the writhing response. Prostaglandins. 1988;36:693-709.

Shibate M, Ohkubo T, Takashi H, Inoki R. Modified formalin test. Pain. 1989;38:345-52.

Correa CR, Calixto JB. Evidence for participation of B1 and B2 kinin receptors in formalin-induced nociceptive response in the mouse. Br J Pharmacol. 1993;110:193-8.

Correa CR, Kyle DJ, Charkraverty S, Calixto JB. Antinociceptive profile of pseudopeptide B2 bradykinin receptor antagonist NPC 18688 in mice. Br J Pharmacol. 1996;117:552-8.

Coderre TJ, Melzack R. The contribution of excitatory amino acids to centrall sensitization and persistent nociception after formalin-induced tissue injury. J Neurosci. 1992;12:3665-70.

Damas J, Liegeois JF. The inflammatory reaction induced by formalin in the rat paw. Naunyn Schneidebergs Arch Pharmacol. 1999;359:200.

Bhakthavatsalam P, Kamatchi GL, Ghosh MN. Dissociation of receptor sensitivity changes in rat perifornical hypothalamus: a role for dopaminergic receptors in amphetamine anorexic tolerance. J Pharmacol Exp Ther. 1987;240:196-202.




How to Cite

Karnam, N., K., J. J., ., S., & ., R. (2017). Screening of a novel-substituted furan compound for analgesic activity in mice. International Journal of Basic & Clinical Pharmacology, 5(5), 1759–1763.



Original Research Articles